1 – 42 of 42
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
An overview of Clinical Quality Registries (CQRs) on gynecological oncology worldwide
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Risk factors for lymph node metastases in women with endometrial cancer : A population-based, nation-wide register study—On behalf of the Swedish Gynecological Cancer Group
(
- Contribution to journal › Article
- 2011
-
Mark
Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer
(
- Contribution to journal › Article
- 2005
-
Mark
Clinical trials in ovarian carcinoma : study methodology
2005) In Annals of oncology : official journal of the European Society for Medical Oncology 16(Suppl 8). p.20-29(
- Contribution to journal › Article
-
Mark
3rd International Ovarian Cancer Consensus Conference : outstanding issues for future consideration
2005) In Annals of oncology : official journal of the European Society for Medical Oncology 16(Suppl 8). p.36-38(
- Contribution to journal › Article
-
Mark
2004 consensus statements on the management of ovarian cancer : final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)
2005) In Annals of oncology : official journal of the European Society for Medical Oncology 16 Suppl 8. p.7-12(
- Contribution to journal › Article
- 2004
-
Mark
A prospective population-based management program including primary surgery and postoperative risk assessment by means of DNA ploidy and histopathology. Adjuvant radiotherapy is not necessary for the majority of patients with FIGO stage I-II endometrial cancer
(
- Contribution to journal › Article
- 2002
-
Mark
TP53 protein expression analysis by luminometric immunoassay in comparison with gene mutation status and prognostic factors in early stage endometrial cancer
(
- Contribution to journal › Article
- 2001
-
Mark
A systematic overview of chemotherapy effects in ovarian cancer
(
- Contribution to journal › Scientific review
-
Mark
The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of chemotherapy effects in some major tumour types--summary and conclusions
(
- Contribution to journal › Scientific review
- 2000
-
Mark
Modeling normal tissue complication probability from repetitive computed tomography scans during fractionated high-dose-rate brachytherapy and external beam radiotherapy of the uterine cervix
(
- Contribution to journal › Article
-
Mark
Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument
2000) In Annals of oncology : official journal of the European Society for Medical Oncology 11(3). p.8-281(
- Contribution to journal › Article
- 1999
-
Mark
Indications for adjuvant radiotherapy in endometrial carcinoma
(
- Contribution to journal › Scientific review
- 1998
-
Mark
Nytt behandlingsprogram vid avancerad ovarialcancer. Tillfredsställande resultat med decentraliserad cytostatikaterapi
(
- Contribution to journal › Article
-
Mark
A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis
(
- Contribution to journal › Article
-
Mark
Long-term results from a phase II study of single agent paclitaxel (Taxol) in previously platinum treated patients with advanced ovarian cancer : the Nordic experience
1998) In Annals of oncology : official journal of the European Society for Medical Oncology 9(12). p.1301-1307(
- Contribution to journal › Article
- 1997
-
Mark
Bättre prognos vid epitelial ovarialcancer
(
- Contribution to journal › Article
-
Mark
Malignant struma ovarii' with peritoneal dissemination
(
- Contribution to journal › Letter
-
Mark
Nytt, dyrare medel mot ovarialcancer. Ar det värt sitt pris?
(
- Contribution to journal › Article
- 1996
-
Mark
Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A
(
- Contribution to journal › Article
-
Mark
Doxorubicin-melphalan with and without cisplatin in advanced ovarian cancer--ten-year survival results from a prospective randomized study by the Swedish Cooperative Ovarian Cancer Study Group
(
- Contribution to journal › Article
- 1995
-
Mark
Primary surgery in ovarian cancer : current opinions
(
- Contribution to journal › Scientific review
-
Mark
Identification of small areas of solid growth has a strong prognostic impact in differentiated endometrial carcinomas. A histopathologic and morphometric study
(
- Contribution to journal › Article
-
Mark
Navoban (tropisetron) alone and in combination with dexamethasone in the prevention of chemotherapy-induced nausea and vomiting : the Nordic experience. The Nordic Antiemetic Trial Group
(
- Contribution to journal › Article
- 1994
-
Mark
A population-based survey of ovarian malignancies in the southeast health care region of Sweden 1984-1987
(
- Contribution to journal › Article
-
Mark
Granulosa cell tumors of the ovary : prognostic factors and outcome
(
- Contribution to journal › Article
-
Mark
Mucinous borderline and malignant tumors of the ovary. A clinicopathologic and DNA ploidy study of 92 cases
(
- Contribution to journal › Article
-
Mark
Efficacy and tolerability of tropisetron in comparison with a combination of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin-containing chemotherapy
(
- Contribution to journal › Article
-
Mark
A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis
(
- Contribution to journal › Article
-
Mark
Tropisetron (Navoban) in the prevention of chemotherapy-induced nausea and vomiting--the Nordic experience
(
- Contribution to journal › Article
- 1993
-
Mark
Monitoring CA 125 serum levels during early chemotherapy is an excellent prognostic method in advanced ovarian cancer
(
- Contribution to journal › Article
-
Mark
Treatment results and prognostic factors in a population-based study of epithelial ovarian cancer
(
- Contribution to journal › Article
-
Mark
Death rate and recurrence pattern among 841 clinical stage I endometrial cancer patients with special reference to uterine papillary serous carcinoma
(
- Contribution to journal › Article
-
Mark
Efficacy and tolerability of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin
1993) In Annals of oncology : official journal of the European Society for Medical Oncology 4(Suppl 3). p.31-34(
- Contribution to journal › Article
- 1992
-
Mark
Long-term follow-up of ovarian cancer with monthly determinations of serum CA 125
(
- Contribution to journal › Article
-
Mark
Nuclear morphometry : a strong prognostic factor for survival after secondary surgery in advanced ovarian cancer
(
- Contribution to journal › Article
- 1991
-
Mark
Postmenopausal extragenital choriocarcinoma. A case report and review of the literature
(
- Contribution to journal › Scientific review
- 1990
-
Mark
Serum half-life of the tumor marker CA 125 during induction chemotherapy as a prognostic indicator for survival in ovarian carcinoma
(
- Contribution to journal › Article
- 1989
-
Mark
The use of chordotomy to treat pain from gynecologic cancer
(
- Contribution to journal › Article
- 1983
-
Mark
Applications of Laser Techniques To Combustion Diagnosis
(
- Contribution to journal › Article
- 1982
-
Mark
Single-pulse Laser-induced Oh Fluorescence In An Atmospheric Flame, Spatially Resolved With A Diode-array Detector
(
- Contribution to journal › Article
- 1973
-
Mark
Effects of high ambient pressure on resistance to anoxia in mice
(
- Contribution to journal › Article